Awarded
Lote 1. Ravulizumab (Ultomiris).
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- ALEXION PHARMA SPAIN, S.L.
- Contract value
- €5,854,033
- Bids received
- 1
- Published
- 3 Aug 2026
- Awarded
- 31 Jul 2026
- Contract start
- 31 Jul 2026
- Contract end
- 1 Aug 2027estimated
- Region
- Cantabria
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Lote 5. Zerbaxa (Ceftolozano Sulfato/Tazobactam Sodico) | Servicio Cántabro de Salud | Merck Sharp and Dohme de España, S.A. | €793,659 | 7 Sept 2026 |
| Lote 4. Winrevair (Sotatercept) | Servicio Cántabro de Salud | Merck Sharp and Dohme de España, S.A. | €1,199,127 | 7 Sept 2026 |
| Lote 3. Prevymis (Letermovir) | Servicio Cántabro de Salud | Merck Sharp and Dohme de España, S.A. | €1,528,474 | 7 Sept 2026 |
| Lote 2. Pifeltro (Doravirina) | Servicio Cántabro de Salud | Merck Sharp and Dohme de España, S.A. | €462,026 | 7 Sept 2026 |
| Contrato de servicios de dirección facultativa para las obras de ampliación de edificio del centro de salud Polanco. | Servicio Cántabro de Salud | sukunfuku studio SLP | €244,895 | 7 Sept 2026 |
| Lote 9. Tremfya (Guselkumab) | Servicio Cántabro de Salud | JANSSEN CILAG, S.A. | €4,060,523 | 2 Sept 2026 |